A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious ...

Higher prevalence was seen for antiviral-treated patients compared with untreated counterparts. (HealthDay News) — Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care ...

As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...

CKD is a widespread condition that not only increases the risk of kidney failure but also significantly raises the risk of developing various forms of cardiovascular disease. A re ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

"The pervasive presence of phthalates results in nearly unavoidable exposure in the general population, with CKD patients likely experiencing even higher levels due to their medical treatment ...

Chronic kidney disease (CKD) is correlated with sudden cardiac death (SCD), according to an October study published in Nature Communications.

Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD ...

ProKidney Corp. (Nasdaq: PROK) ('ProKidney” or the 'Company'), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company ...

In the prevention of kidney disease in patients with type 2 diabetes (T2D) and mildly reduced kidney function, SGLT2 inhibitors (SGLT2i) showed a stronger benefit than GLP-1 receptor agonists (RA) and ...

A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications ...